Background Clinical trials that have assessed the effect of revascularization in patients with
stable coronary disease have routinely excluded those with advanced chronic kidney …

Background Patients with non-left-main coronary bifurcation lesions are usually best treated
with a stepwise provisional approach. However, patients with true left main stem bifurcation …

Despite concordant outcome data from a thousand registries comparing successful versus
unsuccessful CTO PCI (1), recent randomized trials did not support the impact on survival of …

Background Pulmonary artery denervation (PADN) procedure has not been applied to patients
with residual chronic thromboembolic pulmonary hypertension (CTEPH) after pulmonary …

Purpose The combination of left atrial appendage (LAA) occlusion with pulmonary vein
isolation (PVI) potentially represents a comprehensive treatment for atrial fibrillation (AF), …

The implantation of metallic devices in orthopaedic surgical procedures and coronary angioplasty
is associated with the risk of various adverse events: (i) mechanical (premature failure)…

Aims Bioresorbable scaffolds (BRS) provide short-term coronary artery scaffolding and drug
delivery. Although prior trials showed a higher rate of device failure compared with …

Background Improvements in drug-eluting stent design have led to a reduced frequency of
repeat revascularisation and new biodegradable polymer coatings may allow a shorter …

Background Most drug-eluting stent (DES) trials have excluded patients with chronic kidney
disease (CKD). The efficacy of DES implantation in patients with CKD is therefore not known…

AIMS: Bioresorbable scaffolds (BRS) were conceived to ensure transient coronary artery
support during antiproliferative drug delivery. However, the Absorb everolimus-eluting …